Phase III Randomized Trial of Toremifene vs Tamoxifen in Hormonodependant Advanced Breast Cancer
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 65 (2) , 119-124
- https://doi.org/10.1023/a:1006440802709
Abstract
Purpose. Efficacy and safety of toremifene (TOR) 60mgs/dayly/o.r. was compared with tamoxifen (TAM) 40mgs/dayly/o.r. in a group of postmenopausal women with advanced breast cancer, without previous...Keywords
This publication has 21 references indexed in Scilit:
- Genotoxicity Studies with the Antiestrogen ToremifeneDrug and Chemical Toxicology, 1998
- ToremifeneDrugs, 1997
- Tamoxifen and Secondary TumoursDrug Safety, 1997
- Second Cancers After Adjuvant Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1996
- A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer PatientsGynecologic Oncology, 1995
- Should clinicians be concerned about the carcinogenic potential of tamoxifen?European Journal Of Cancer, 1994
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In VitroJNCI Journal of the National Cancer Institute, 1993
- An analysis of variance test for normality (complete samples)Biometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958